THIODERM ELATE for Volume Augmentation in Lips

计划入组 266 人 · 首次发布于 2023 年 11 月 15 日

Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining

计划入组 105 人 · 首次发布于 2013 年 5 月 27 日

DuoTrav APS Versus XALACOM® in Ocular Surface Health

计划入组 240 人 · 首次发布于 2009 年 6 月 3 日

X-Synergy®

NanoLithium® NP03

Integra®-SC

Ocular Therapeutix

United States

Ocular Therapeutix, Inc.

United States

Refocus Group, Inc.

United States

Cambium Bio Raises A$10.85M to Launch Pivotal Phase 3 Trial of Elate Ocular in Dry Eye Disease

Locus Cell Secures First International Phase III CDMO Partnership with Cambium Bio for Dry Eye Therapy

FDA Approves Protocol for Cambium Bio's Phase 3 Trial of Elate Ocular in Dry Eye Disease